PODCAST · health
Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM
by Annenberg Center for Health Sciences
Myasthenia gravis, an autoimmune disease characterized by fluctuating muscle weakness, greatly impacts patients’ functioning and activities of daily living. Important treatment advances continue to be made to reduce patient burden of disease and overcome safety, efficacy, and other limitations of available therapies. Join Nicholas Silvestri, MD, as he reports on research results of some of these advances presented at the 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting.
-
6
-
5
Long-Term Safety and Efficacy of Zilucoplan in Generalized Myasthenia Gravis 120-Week Interim Analysis of RAISE-XT
Author: Howard, JF, et al.Overview Provided by Nicolas Silvestri, MD
-
4
Efficacy and Safety of Nipocalimab in Patients with Generalized Myasthenia Gravis: Topline Results from the Double-Blind, Placebo-Controlled, Randomized Phase 3 VIVACITY-MG3 Study
Author: Strober J, et al.Overview Provided by Nicolas Silvestri, MD
-
3
Concomitant Corticosteroid Use with Ravulizumab in Adults with Anti-Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: Phase 3 CHAMPION-MG Open-Label Extension Final Results
Author: Nicolle M, et al.Overview Provided by Nicolas Silvestri, MD
-
2
Cyclic and Every-Other-Week Dosing of Intravenous Efgartigimod for Generalized Myasthenia Gravis Part A of ADAPT NXT
Author: Habib AA, et alOverview Provided by Nicolas Silvestri, MD
-
1
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Myasthenia gravis, an autoimmune disease characterized by fluctuating muscle weakness, greatly impacts patients’ functioning and activities of daily living. Important treatment advances continue to be made to reduce patient burden of disease and overcome safety, efficacy, and other limitations of available therapies. Join Nicholas Silvestri, MD, as he reports on research results of some of these advances presented at the 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting.
HOSTED BY
Annenberg Center for Health Sciences
Loading similar podcasts...
Frequently Asked Questions
How many episodes does Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM have?
Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM currently has 6 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM about?
Myasthenia gravis, an autoimmune disease characterized by fluctuating muscle weakness, greatly impacts patients’ functioning and activities of daily living. Important treatment advances continue to be made to reduce patient burden of disease and overcome safety, efficacy, and other limitations of...
How often does Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM release new episodes?
Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM has 6 episodes. Check the episode list to see recent publication dates and frequency.
Where can I listen to Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM?
You can listen to Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM?
Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM is created and hosted by Annenberg Center for Health Sciences.
URL copied to clipboard!